| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,526 |
5,469 |
$315K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,641 |
2,808 |
$273K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,461 |
2,826 |
$260K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,680 |
2,365 |
$200K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,118 |
1,804 |
$145K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,265 |
1,108 |
$104K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,260 |
678 |
$64K |
| 96127 |
|
3,356 |
2,915 |
$60K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
826 |
597 |
$37K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,633 |
1,418 |
$32K |
| 92551 |
|
1,874 |
1,716 |
$29K |
| 99000 |
|
1,459 |
1,111 |
$18K |
| 90670 |
|
1,408 |
1,171 |
$17K |
| D1206 |
Topical application of fluoride varnish |
552 |
499 |
$14K |
| 90686 |
|
1,283 |
1,145 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
743 |
672 |
$12K |
| 90648 |
|
1,344 |
1,054 |
$11K |
| 83655 |
|
891 |
702 |
$11K |
| 90680 |
|
817 |
666 |
$9K |
| 90633 |
|
805 |
665 |
$8K |
| 36416 |
|
1,667 |
1,410 |
$7K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
456 |
397 |
$7K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
215 |
135 |
$6K |
| 90723 |
|
775 |
646 |
$6K |
| 90671 |
|
304 |
270 |
$6K |
| 92587 |
|
418 |
342 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
66 |
55 |
$5K |
| 99051 |
|
1,692 |
1,334 |
$4K |
| 0072A |
|
85 |
82 |
$3K |
| 90697 |
|
174 |
145 |
$3K |
| 90619 |
|
169 |
124 |
$3K |
| 85018 |
|
1,001 |
793 |
$2K |
| 94664 |
|
115 |
93 |
$2K |
| 0071A |
|
35 |
33 |
$1K |
| 90672 |
|
93 |
86 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
53 |
51 |
$1K |
| 90651 |
|
37 |
37 |
$1K |
| 99215 |
Prolong outpt/office vis |
17 |
17 |
$1K |
| 90715 |
|
59 |
54 |
$1K |
| 90734 |
|
97 |
79 |
$1K |
| 90656 |
|
56 |
48 |
$964.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
26 |
17 |
$883.25 |
| 0001A |
|
20 |
20 |
$842.80 |
| 0002A |
|
20 |
20 |
$842.80 |
| 90685 |
|
98 |
83 |
$728.28 |
| 90710 |
|
67 |
52 |
$711.57 |
| 90661 |
|
42 |
36 |
$701.82 |
| 90696 |
|
87 |
69 |
$556.80 |
| 90707 |
|
18 |
17 |
$554.32 |
| 90700 |
|
42 |
24 |
$453.60 |
| 83718 |
|
50 |
50 |
$398.08 |
| 94760 |
|
1,142 |
860 |
$276.80 |
| 90698 |
|
14 |
14 |
$233.94 |
| 82465 |
|
50 |
50 |
$207.76 |
| 99177 |
|
1,288 |
1,159 |
$162.43 |
| 90716 |
|
13 |
12 |
$124.00 |
| 90461 |
|
3,058 |
2,514 |
$78.00 |
| 1036F |
|
1,187 |
1,022 |
$0.00 |
| 1220F |
|
671 |
602 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17 |
17 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,325 |
4,594 |
$0.00 |
| 1003F |
|
4,112 |
3,487 |
$0.00 |
| 99072 |
|
1,375 |
1,158 |
$0.00 |